This is an exceptionally good result for a diagnostic test
Pancreatic cancer is often detected at a late stage, which results in poor prognosis and limited treatment options. Researchers at The Sahlgrenska Academy have now developed a method which identifies the cancer’s visible precursors with 97% certainty. The method, which is expected to aid in the early discovery of the cancer as well as minimize the risk of unnecessary surgery, may be introduced in patient care within five years.
The poor prognosis for pancreatic cancer, where only 5 percent of the patients survive five years after the diagnosis, is due to the fact that the tumors often develop unnoticed, and rarely cause symptoms until they have spread to other organs.
Recent studies, however, have shown that fluid-filled compartments in the pancreas, called cysts, may be precursors of the cancer.
Hard to identify harmful cysts
Cysts in the pancreas, which are found in every 10th person above the age of 70, and are also common in younger people, can be discovered with computed tomography (CT) or magnetic resonance imaging (MRI).
The problem is that imaging alone cannot determine which cysts are at risk for developing into cancer. Therefore, it often becomes necessary to puncture the cyst and look for tumor markers in the cyst fluid but not even these analyses are reliable.
Removing the cyst by surgery, with the knowledge that it may turn out to be completely benign, is also problematic since the operation is extensive, with considerable risks for the patient.
97 percent certainty
Researchers at The Sahlgrenska Academy, University of Gothenburg, have now developed a method which can predict with 97 percent certainty which pancreatic cysts constitute precursors to cancer. With this method, which detects the presence of mucus protein, mucins, in the cystic fluid, the researchers were able to reach the correct diagnosis in 77 of 79 cysts that were examined.
– This is an exceptionally good result for a diagnostic test, and we are very hopeful that the method will enable more instances of early discovery of pancreatic cancer, at a stage when the cancer can be treated or prevented. This approach may also minimize the risk of unnecessary operations on non-malignant cysts, said Karolina Jabbar, PhD student at The Sahlgrenska Academy and physician at The Sahlgrenska University Hospital.
Helps operation decisions
The researchers have also tested the new method in order to analyze existing tumors and, with about 90 percent certainty, have been able to determine which tumors have already developed into cancers. This means that the method could also be used to determine which patients require immediate surgery, and when it is instead possible to wait and monitor the development of the cyst.
The method which has been used in the study is called proteomics, which means the analysis of the protein content of a tissue or fluid with the help of mass spectrometry . This method has thus far been used in research. But Professor Gunnar C. Hansson who, together with senior physician and Assistant Professor Riadh Sadik, initiated the study, is convinced that the proteomics will soon be introduced in health care.
– The technique has been developed, and we can now measure biomarkers both quickly and exactly. Moreover, the method requires minimal biomaterial, in this case 25 times less cyst fluid than conventional tumor marker analyses. I am certain that within five years the mass spectrometers will have moved into the hospital corridors, he said.
The Latest on: Pancreatic Cancer
[google_news title=”” keyword=”Pancreatic Cancer” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Pancreatic Cancer
- Pancreatic cancer survivor fighting for early screeningon May 5, 2024 at 2:41 pm
Pancreatic cancer is among the deadliest of cancers - from diagnosis to death is normally four to nine months. But early detection can be the key to survival. Newshub National Correspondent Amanda ...
- Unite in the Fight: celebrating those who've conquered and are still fighting canceron May 4, 2024 at 8:16 pm
On Saturday, the Georgia Cancer Center hosted its annual Unite in the Fight Against Cancer. Survivors, friends and family joined in one mile walk celebrating and honoring those who have been impacted ...
- Cold Spring Harbor Lab wins $15 million from NYS for pancreatic cancer researchon May 4, 2024 at 4:08 am
The state will put $15 million toward a $30 million research center at Cold Spring Harbor Laboratory for pancreatic cancer, a disease that is fatal for most people, Gov. Kathy Hochul told Newsday on ...
- MicroRNAs May Predict Pancreatic Cancer Risk Years Before Diagnosison May 3, 2024 at 7:15 am
Expression levels of several microRNAs in plasma samples can help predict the onset of pancreatic cancer up to 5 years prior to clinical diagnosis.
- Pancreatic cancer is difficult to treat. Nano-drugs hitching a ride on bacteria could helpon May 1, 2024 at 5:00 pm
Many pancreatic tumors are like malignant fortresses, surrounded by a dense matrix of collagen and other tissue that shields them from immune cells and immunotherapies that have been effective in ...
- Pancreatic Cancer Cells Differ by Location and May Inform Targeted Treatmentson May 1, 2024 at 5:00 pm
A new study has found that pancreatic cancer cells are different based on their location in the pancreas, providing new information about tumors that could lead to better targeted treatments.
- Researchers find difference in pancreatic cancer cells, offering new hope for immunotherapy effectivenesson May 1, 2024 at 6:42 am
A new study has found that pancreatic cancer cells are different based on their location in the pancreas, providing new information about tumors that could lead to better targeted treatments.
- Pancreatic Cancer: Successful Trial Against Pancreatic Cancer with Defence Therapeutics' ARM-002 Anti-Cancer Vaccineon May 1, 2024 at 12:15 am
Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC), ("Defence" or the "Company"), a Canadian biopharmaceutical company developing novel immune-oncology therapeutics and drug delivery ...
- PurpleStride Pittsburgh charity walk raises money for pancreatic cancer researchon April 29, 2024 at 7:17 am
The Pancreatic Cancer Action Network held Purple Stride Pittsburgh, where survivors, families, caregivers, researchers and supporters raise money through the walk. KDKA-TV's Kristine Sorensen served ...
- What Is Pancreatic Cancer?on April 22, 2024 at 5:30 am
Pancreatic cancer develops when abnormal cells in the pancreas grow and divide uncontrollably, forming a tumor. The pancreas is a glandular organ nestled between the stomach and the spine that ...
via Bing News